KEYNOTE 590 PEMBROLIZUMAB - AN OVERVIEW

This prevents the activation on the T-cell which Generally would target and wipe out cancer. The cancer cells can then multiply and unfold. When Keytruda binds for the PD-one receptor it stops cancer cells from linking to and inactivating T-cells, enabling T-cell re-activation, and boosting the immune system's response against cancer. This affects